Generative models for structure-based molecular design hold considerable promise for drug discovery, with the potential to speed up the hit-to-lead development cycle while improving the quality of ...

AI-driven generative design automates the exploration of thousands of design permutations, significantly reducing development cycles and costs. Integration of simulation and manufacturing constraints ...